Earnings
KULR Technology Group posts Q2 2026 loss, misses revenue estimates
Thermal management firm KULR Technology Group reported a wider-than-expected loss and revenue shortfall for Q2 2026, citing soft demand and supply chain pressures.
Xos Q2 2026 revenue falls short, shares slump in after-hours trade
Electric truck maker Xos reported second-quarter 2026 revenue below expectations, triggering a sharp decline in its stock during extended trading.
Oxbridge Q2 2026 profit rises, shares gain on AI strategy
Shares of Oxbridge advanced after the company reported a higher-than-expected profit for Q2 2026 and outlined plans to expand its artificial intelligence initiatives.
Bridgeline Digital Q3 2026 revenue falls short, shares drop
Digital solutions provider posts lower-than-expected Q3 2026 revenue, triggering a decline in its stock price.
Smith Micro Q2 2026 earnings miss despite improved growth
Software firm Smith Micro Software reported second-quarter 2026 results below market expectations, though revenue and profitability showed sequential improvement.
PetMed Express Q1 2027 earnings miss sends shares lower
PetMed Express reported first-quarter results below Wall Street estimates, with shares sliding in after-hours trading. The company cited weaker-than-expected demand and rising operational costs.
Aethlon Medical Q1 2026 loss misses estimates despite trial progress
Biotech firm reports wider-than-expected quarterly loss as clinical trial advances. Shares slip on earnings miss.
Rekor Systems Q2 2026 earnings: EPS beats as revenue falls short
Rekor Systems reported second-quarter 2026 earnings per share that exceeded expectations, though revenue missed analyst forecasts. Shares were little changed in after-hours trading.
Grandstand Q2 2026 earnings stable, shares slip on call
Company reports steady quarterly results but faces investor skepticism despite financial stability.
Vuzix Q2 2026 revenue falls short of estimates, shares drop
Smart glasses maker Vuzix reported second-quarter 2026 revenue below analyst expectations, triggering an after-hours selloff in its shares.
VirTra Q2 2026 earnings beat lifts shares in after-hours trade
Defense training simulator maker VirTra reported second-quarter 2026 results above Wall Street estimates, sending shares higher in extended trading.
NextBoat posts record Q2 2026 revenue but shares fall
Revenue growth misses market expectations despite record quarterly earnings, triggering investor caution.
ARS Pharmaceuticals shares drop on Q2 2026 earnings report
Shares of ARS Pharmaceuticals declined after the company released its second-quarter 2026 earnings results, citing revenue shortfalls and revised guidance.
TechPrecision Q1 2027 revenue rises 23%, shares surge
Precision components maker TechPrecision reported a 23% year-over-year revenue increase for Q1 2027, lifting its stock in after-hours trading.
Co-Diagnostics narrows Q2 loss but revenue remains weak
Diagnostics firm Co-Diagnostics reported a reduced net loss in Q2 2026, though revenue growth remained subdued amid ongoing market challenges.
Genasys Q3 2026 earnings miss sends shares lower in after-hours trade
Genasys reported third-quarter 2026 results below analyst expectations, with its stock falling in extended trading as investors reacted to the shortfall.
4D Molecular misses earnings by $0.03, revenue beats forecasts
Biotech firm 4D Molecular Therapeutics reported adjusted EPS of $0.67, below expectations, while revenue reached $12.3 million, exceeding analyst estimates.
Assembly Biosciences tops earnings, revenue forecasts
Drug developer Assembly Biosciences reported adjusted EPS of $0.53, beating expectations, while revenue exceeded analyst estimates for the quarter.
Boston Omaha posts Q3 earnings miss, revenue below forecasts
Boston Omaha reported third-quarter earnings per share $0.02 below estimates and revenue that trailed analyst projections, extending a streak of underperformance.
KULR Technology Group posts quarterly loss, misses revenue forecasts
Revenue declined 12% year-over-year as expenses rose, leading to a per-share loss of $0.39 versus estimates of $0.02. Shares fell 5% in after-hours trading.
Genasys misses earnings by 12 cents, revenue below forecasts
Quarterly profit fell short of analyst estimates as revenue declined, pressuring shares in after-hours trading.
MacroGenics reports Q2 loss, misses revenue and earnings estimates
Biotech firm MacroGenics posted a wider-than-expected quarterly loss and revenue below forecasts, sending shares lower in after-hours trading.
Nektar Therapeutics Q2 earnings beat estimates, revenue misses
Nektar Therapeutics reported adjusted earnings per share of $0.77 above estimates, while revenue fell short of analyst projections in the second quarter.
Elutia misses earnings by $0.02, revenue below estimates
Specialty pharma firm Elutia reported adjusted earnings per share of $0.48, missing the $0.50 forecast. Revenue declined 3% year-over-year to $125 million.